1.
Kader S, J.Al-Shamma K, A. Majeed I, T. Al-Ani A. Comparative Study between Oral Hypoglycemic Drugs Repaglinide, Glibenclamide and Rosiglitazone on Some Biochemical Parameters in Type 2 Diabetic Patients. Iraqi Journal of Pharmaceutical Sciences [Internet]. 2017 Mar. 30 [cited 2024 Nov. 5];18(2):32-8. Available from: https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/530